The HCPLive Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.
December 9th 2024
In this month's episode of Lungcast, Jacob Sands, MD, discusses the American Lung Association’s recently newly-released 2024 State of Lung Cancer report.
CHA2DS2-VASc Scores Useful Even When Patients Do Not Have Atrial Fibrillation
The scoring system known as CHA2DS2-VASc is commonly used as a clinical guideline for assessing ischemic stroke risk in patients with atrial fibrillation (AF). A research team from Santiago, Chile found it can also predict vascular dysfunction and cardiovascular events in high-risk patients who do not have AF.
Q&A With Bryan Martin From The Ohio State University: ACAAI Aims To Move Field Into The Future
The world of medicine is changing and because of that organizations need to change as well. The American College of Allergy, Asthma, & Immunology is no exception to that trend.
Tiotropium Inhaler Add-On Improves Lung Function in Young Asthmatic Patients
November 8th 2015Even with the combination of inhaled corticosteroids (ICS) and long-acting beta agonists (LABAs), about 46% of young patients still suffer from poorly controlled asthma. A new analysis found that an add-on inhaler may be just what patients need to reach improved lung function.
Adherence to Omalizumab Does Not Correlate with Better Response for Asthma
November 8th 2015While clinicians should always encourage their patients to follow their medication schedules, it proved not to be a significant factor in the outcomes in patients with asthma taking omalizumab, according to a poster session at the 2015 American College of Allergy, Asthma, and Immunology Annual Scientific Meeting (ACAAI 2015) in San Antonio, Texas.
Asthma in Review: What Have We Learned This Past Year?
November 6th 2015A presentation at the 2015 ACAAI Annual Meeting reviewed several key developments in the world of asthma that were published within the past year. The four main takeaways touched on the inhalant SB010, severe refractory asthma, medication during pregnancy, and the use of tiotropium.
Q&A With Daniel Ouellette From Henry Ford Hospital: Benefits Seen In Raising Smoking Age To 21
With the federal government leaving it to state and local entities to determine the age at which tobacco products can be purchased, an effort is underway to advance the age limit three years to 21.
COPD: Comorbidities in a High-Risk State
In Kentucky, chronic obstructive pulmonary disease (COPD) and multiple comorbidities are major public health issues, and there is variation in the occurrence of both COPD and the various comorbidities depending on both gender and where in the state people live. A research team looked at the factors contributing to both.
Patients with COPD Become More Physically Inactive Over Time, Worsening Their Disease
Physical activity declines over time in patients with chronic obstructive pulmonary disease (COPD), independent of disease severity. This decline is also associated with worsening lung function and loss of quality of life and health status.
In the world of pulmonary conditions idiopathic pulmonary fibrosis is among the rarest, and up until recently there were no treatments available to help these patients. With the approval of OFEV there is now something that can be done while more research is conducted.